Tachibana O - Search Results

1

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H. Watanabe K, et al. Among authors: tachibana o. Brain Pathol. 1996 Jul;6(3):217-23; discussion 23-4. doi: 10.1111/j.1750-3639.1996.tb00848.x. Brain Pathol. 1996. PMID: 8864278

2

Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.

Arakawa Y, Tachibana O, Hasegawa M, Miyamori T, Yamashita J, Hayashi Y. Arakawa Y, et al. Among authors: tachibana o. Acta Neuropathol. 2005 Mar;109(3):294-8. doi: 10.1007/s00401-004-0956-6. Epub 2004 Dec 31. Acta Neuropathol. 2005. PMID: 15627206

3

Frequent LOH at chromosome 12q22-23 and Apaf-1 inactivation in glioblastoma.

Watanabe T, Hirota Y, Arakawa Y, Fujisawa H, Tachibana O, Hasegawa M, Yamashita J, Hayashi Y. Watanabe T, et al. Among authors: tachibana o. Brain Pathol. 2003 Oct;13(4):431-9. doi: 10.1111/j.1750-3639.2003.tb00474.x. Brain Pathol. 2003. PMID: 14655749

4

Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.

Sure U, Rüedi D, Tachibana O, Yonekawa Y, Ohgaki H, Kleihues P, Hegi ME. Sure U, et al. Among authors: tachibana o. J Neuropathol Exp Neurol. 1997 Jul;56(7):782-9. J Neuropathol Exp Neurol. 1997. PMID: 9210874

5

Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas.

Tohma Y, Gratas C, Van Meir EG, Desbaillets I, Tenan M, Tachibana O, Kleihues P, Ohgaki H. Tohma Y, et al. Among authors: tachibana o. J Neuropathol Exp Neurol. 1998 Mar;57(3):239-45. doi: 10.1097/00005072-199803000-00005. J Neuropathol Exp Neurol. 1998. PMID: 9600216

6

Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.

Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H. Watanabe K, et al. Among authors: tachibana o. Clin Cancer Res. 1997 Apr;3(4):523-30. Clin Cancer Res. 1997. PMID: 9815715

7

Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.

Gratas C, Tohma Y, Van Meir EG, Klein M, Tenan M, Ishii N, Tachibana O, Kleihues P, Ohgaki H. Gratas C, et al. Among authors: tachibana o. Brain Pathol. 1997 Jul;7(3):863-9. doi: 10.1111/j.1750-3639.1997.tb00889.x. Brain Pathol. 1997. PMID: 9217971 Clinical Trial.

8

Role of gemistocytes in astrocytoma progression.

Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H. Watanabe K, et al. Among authors: tachibana o. Lab Invest. 1997 Feb;76(2):277-84. Lab Invest. 1997. PMID: 9042164

9

Preferential expression of Fas/APO1 (CD95) and apoptotic cell death in perinecrotic cells of glioblastoma multiforme.

Tachibana O, Lampe J, Kleihues P, Ohgaki H. Tachibana O, et al. Acta Neuropathol. 1996 Nov;92(5):431-4. doi: 10.1007/s004010050542. Acta Neuropathol. 1996. PMID: 8922052

10

Expression of Fas/APO-1 during the progression of astrocytomas.

Tachibana O, Nakazawa H, Lampe J, Watanabe K, Kleihues P, Ohgaki H. Tachibana O, et al. Cancer Res. 1995 Dec 1;55(23):5528-30. Cancer Res. 1995. PMID: 7585627

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results